EUS-CPN: A Retrospective Review

This study has been completed.
Sponsor:
Information provided by:
Indiana University
ClinicalTrials.gov Identifier:
NCT00577564
First received: December 19, 2007
Last updated: September 11, 2012
Last verified: September 2012
  Purpose

The purpose of this retrospective study is to measure the safety of EUS-CPN in patients that have undergone this procedure in the last decade.


Condition
Pancreatic Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN): A Retrospective Review of Safety

Resource links provided by NLM:


Further study details as provided by Indiana University:

Primary Outcome Measures:
  • Number of EUS-CPN procedures for each patient [ Time Frame: over a ten year period ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Procedure-related complications [ Time Frame: over a ten year period ] [ Designated as safety issue: Yes ]

Study Start Date: July 2006
Study Completion Date: December 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients that underwent a EUS-CPN over a ten year period at Indiana University Medical Center will be considered.

Criteria

Inclusion Criteria:

  • Any subject that has undergone EUS-CPN will be considered for this study.

Exclusion Criteria:

  • Subjects will be excluded if they have undergone a celiac plexus neurolysis (endoscopic, percutaneous, or surgical) at an another institution.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00577564

Locations
United States, Indiana
Clarian: University Hospital
Indianpolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Investigators
Principal Investigator: Julia LeBlanc, MD, MPH Indiana University School of Medicine
  More Information

No publications provided

Responsible Party: Dr. Julia LeBlanc, Indiana University Medical Center
ClinicalTrials.gov Identifier: NCT00577564     History of Changes
Other Study ID Numbers: 0606-59, IRB #0606-59
Study First Received: December 19, 2007
Last Updated: September 11, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Pancreatic Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on April 16, 2014